These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35494080)

  • 21. Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer.
    Wajant H; Beilhack A
    Front Immunol; 2019; 10():2040. PubMed ID: 31555271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.
    Yang S; Wang J; Brand DD; Zheng SG
    Front Immunol; 2018; 9():784. PubMed ID: 29725328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment.
    Al-Hatamleh MAI; E A R ENS; Boer JC; Ferji K; Six JL; Chen X; Elkord E; Plebanski M; Mohamud R
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting TNFR2 in Cancer: All Roads Lead to Rome.
    Bai J; Ding B; Li H
    Front Immunol; 2022; 13():844931. PubMed ID: 35251045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer.
    Chen X; Oppenheim JJ
    Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases.
    Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P
    Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of TNFR2 agonists: a mechanistic perspective.
    Chen Y; Jiang M; Chen X
    Front Immunol; 2023; 14():1209188. PubMed ID: 37662935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.
    Moatti A; Debesset A; Pilon C; Beldi-Ferchiou A; Leclerc M; Redjoul R; Charlotte F; To NH; Bak A; Belkacemi Y; Salomon BL; Issa F; Michonneau D; Maury S; Cohen JL; Thiolat A
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.
    Nie Y; He J; Shirota H; Trivett AL; Yang D; Klinman DM; Oppenheim JJ; Chen X
    Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
    Torrey H; Butterworth J; Mera T; Okubo Y; Wang L; Baum D; Defusco A; Plager S; Warden S; Huang D; Vanamee E; Foster R; Faustman DL
    Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant expression, purification and characterization of human soluble tumor necrosis factor receptor 2.
    Li A; Sun K; Wang J; Wang S; Zhao X; Liu R; Lu Y
    Protein Expr Purif; 2021 Jun; 182():105857. PubMed ID: 33639277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target.
    Medler J; Wajant H
    Expert Opin Ther Targets; 2019 Apr; 23(4):295-307. PubMed ID: 30856027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4
    Chen S; Li R; Chen Y; Chou CK; Zhang Z; Yang Y; Liao P; Wang Q; Chen X
    Biomed Pharmacother; 2022 Jul; 151():113187. PubMed ID: 35676787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The implications of the TNFα-TNFR2 immune checkpoint signaling pathway in cancer treatment: From immunoregulation to angiogenesis.
    Emamalipour M; Shamdani S; Mansoori B; Uzan G; Naserian S
    Int J Cancer; 2025 Jan; 156(1):7-19. PubMed ID: 39140321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer's Disease.
    Ortí-Casañ N; Wu Y; Naudé PJW; De Deyn PP; Zuhorn IS; Eisel ULM
    Front Neurosci; 2019; 13():49. PubMed ID: 30778285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity.
    Yang M; Tran L; Torrey H; Song Y; Perkins H; Case K; Zheng H; Takahashi H; Kuhtreiber WM; Faustman DL
    J Leukoc Biol; 2020 Jun; 107(6):971-980. PubMed ID: 32202358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
    Zou H; Li R; Hu H; Hu Y; Chen X
    Front Immunol; 2018; 9():594. PubMed ID: 29632537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.